Announcements
Excerpt from the Press Release: Indications include metachromatic leukodystrophy, a rare, progressive, and fatal disease affecting the nervous system, and brain metastases secondary to HER2+ breast cancer, a common and deadly form of cancer – Affinia Therapeutics to use its proprietary technologies and capsids with improved properties to bring the promise of gene therapy to…
Read More
Excerpt from the Press Release: Commonly used recurrence risk tests found to be useful for male patients Breast cancer is usually thought of as a disease that affects women, but many are not aware that men can develop breast cancer as well. Two-hundred and forty men in Canada were diagnosed with the disease in 2020…
Read More
Excerpt from the Press Release: Discovery could provide early warning for blood malignancies, triggering proactive screening and enabling early treatment Toronto – (August 17, 2021) As people age, mutations can build up in blood stem cells and their clones in a process known as age-related clonal hematopoiesis, or ARCH. ARCH can be a risk factor…
Read More
Excerpt from the Press Release: Stanford University is expanding its free repository of imaging and healthcare datasets for artificial intelligence researchers around the globe. The California school’s Center for Artificial Intelligence in Medicine and Imaging first opened in 2019 and has since amassed annotated datasets for more than 1 million images. AIMI is now partnering…
Read More
Excerpt from the Press Release: CARLSBAD, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) — Pardes Biosciences, Inc., a clinical-stage biopharmaceutical company today announced the initiation of a Phase 1 clinical trial, evaluating the company’s lead candidate, PBI-0451 which is being developed as a potential oral direct-acting antiviral to treat and prevent infections with SARS-CoV-2, the virus…
Read More
Excerpt from the Press Release: SAN DIEGO, Aug. 25, 2021 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc. (eFFECTOR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today completed its business combination with Locust Walk Acquisition Corp. (NASDAQ: LWAC). The resulting combined company (the Company) has been renamed “eFFECTOR Therapeutics, Inc.” and…
Read More
Excerpt from the Press Release: PLYMOUTH MEETING, Pa., Aug. 26, 2021 /PRNewswire/ — INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today announced that it has received regulatory authorization from Brazil’s ANVISA (Agência Nacional de Vigilância Sanitária), the national health regulatory agency of Brazil,…
Read More
Excerpt from the Press Release: SAN FRANCISCO and LOS ANGELES, Aug. 26, 2021 /PRNewswire/ — Curebase, a company committed to democratizing access to clinical studies, and AppliedVR, a pioneer advancing the next generation of digital medicine, today announced a one-year partnership where AppliedVR will deploy the Curebase platform to run five clinical trials assessing the effectiveness of virtual reality-based (VR)…
Read More
Excerpt from the Press Release: SAN DIEGO, Aug. 26, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19, today announced promising preclinical results for its mRNA vaccine against SARS-CoV-2. STI-mRNA is comprised of proprietary designer Spike-encoding mRNAs to…
Read More
Excerpt from the Press Release: CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. today announced a partnership to integrate its comprehensive genomic profiling (CGP) and other testing services with Epic’s electronic medical record (EMR) system. Once completed, all providers who use Foundation Medicine’s instance of Epic will be able to electronically order Foundation Medicine tests within the Epic network.…
Read More